RxDoctor Payments Data

Katherine Mistretta, MD

Adult Reconstructive Orthopaedic Surgery · Saint Louis, MONPI 1326543968

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (58.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Medical Device Business Services, Inc. at 56.7% of the total. 2025 is the largest year on record at $22,117, more than ten times the $882 reported in 2023.

$40,991in general payments, 2019–2025

Across 82 payments — averaging $499.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$23K
  • Depuy Synthes Products, Inc.$6K
  • Zimmer Biomet$5K
  • Smith+Nephew$5K
  • Stryker$762
  • Johnson & Johnson$395
  • plus $347 from 4 others

What the payments were for

  • Consulting fees$23,99459%
  • Grants$4,27910%
  • Travel & lodging$7,43618%
  • Food & beverage$5,28113%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$40,991 in reported general payments places this provider in the 70th percentile of 36 adult reconstructive orthopaedic surgery providers in Missouri.

See all adult reconstructive orthopaedic surgery providers in Missouri

Medicare billing

Part B allowed, 2024
$70,759
Medicare patients
190
Services billed
228

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl161$952
Tramadol Hcl183$579
Meloxicam42$141
Pregabalin16$127

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →